Use of remifentanil to reduce propofol injection pain and the required propofol dose in upper digestive tract endoscopy diagnostic tests
BACKGROUND AND OBJECTIVES: The introduction of propofol (2,6-diisopropylphenol) as a sedative agent has transformed the area of sedation for endoscopic procedures. However, a major drawback of sedation with the use of propofol is its high incidence of injection pain. The most widely used technique in reducing propofol injection pain is through the association of other drugs. The aim of this study was to evaluate the effect of remifentanil-propofol combination on the incidence of propofol injection pain and its influence on the total dose of propofol required for sedation in upper digestive tract endoscopy (UDE) diagnostic tests. METHOD: One hundred and five patients undergoing upper digestive tract endoscopy were evaluated and randomly divided into 3 groups of 35 patients each. The Control Group received propofol alone; Study-group 1 received remifentanil at a fixed dose of 0.2 mg/kg combined with propofol; Study-group 2 received remifentanil at a fixed dose of 0.3 mg/kg combined with propofol. The incidence of propofol injection pain and the total dose of propofol required for the test were evaluated. The sample was very similar regarding age, weight, height, sex, and physical status. Statistical analysis was performed according to the nature of the evaluated data. Student'st-test was used to compare the mean of age, weight, height (cm), and dose (mg/kg) variables between groups. The χ2 test was used to compare sex, physical status, and propofol injection pain between groups. The significance level was a < 0.05. RESULTS: There was significant statistical difference between the study groups and the control group regarding the parameters of propofol injection pain and total dose of propofol (mg/kg) used. However, there were no statistical differences between the two study groups for these parameters. CONCLUSION: We conclude that the use of remifentanil at doses of 0.2 mg/kg and 0.3 mg/kg was effective for reducing both the propofol injection pain and the total dose of propofol used.
Main Authors: | Uliana,Gustavo Nadal, Tambara,Elizabeth Milla, Baretta,Giorgio Alfredo Pedroso |
---|---|
Format: | Digital revista |
Language: | English |
Published: |
Sociedade Brasileira de Anestesiologia
2015
|
Online Access: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0034-70942015000600437 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effects of remifentanil on awakening of propofol sedated patients submitted to upper gastrointestinal endoscopy: a randomized clinical trial
by: Uliana,Gustavo Nadal, et al.
Published: (2020) -
Comparing the pain of propofol via different combinations of fentanyl, sufentanil or remifentanil in gastrointestinal endoscopy
by: Zhang,Lifeng, et al.
Published: (2014) -
Anesthesia recovery comparison between remifentanil-propofol and remifentanil-desflurane guided by Bispectral Index® monitoring
by: Rocha,Raphael Grossi, et al.
Published: (2017) -
To study the effect of injection dexmedetomidine for prevention of pain due to propofol injection and to compare it with injection lignocaine
by: Sapate,Manisha, et al.
Published: (2015) -
Remifentanil associado ao propofol ou sevoflurano para colecistectomia videolaparoscópica: estudo comparativo
by: Estivalet,Fernanda Fischer, et al.
Published: (2002)